drugset
drugset / Trial / NCT01814709

A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers

NCT01814709 ↗

Phase 1 Completed 32 enrolled Genentech, Inc.
RandomizedParallel-groupOpen-label

Summary

This open-label, two-arm, drug interaction study will investigate the effect of co-administration of rifampin or itraconazole on the pharmacokinetics of GDC-0032 in healthy volunteers. In Arm A, volunteers will receive GDC-0032 and rifampin; in Arm B, volunteers will receive GDC-0032 and itraconazole. The anticipated time on study treatment is approximately 30 days.

Timeline

Start
2013-04
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — Oral
Subject Rifampin Small molecule — Oral
Subject Taselisib Small molecule — Oral

Indications

No indication recorded.